Malàisia - anglès - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

allergan malaysia sdn bhd - gatifloxacin -

Malàisia - anglès - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

allergan malaysia sdn bhd - brimonidine tartrate -

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

amo australia pty limited (nz) - disodium edetate dihydrate 0.01%; sodium chloride 0.9%;  ;  ; thiomersal 0.00115% - contact lens solution - active: disodium edetate dihydrate 0.01% sodium chloride 0.9%     thiomersal 0.00115%

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

sanofi - alimemazine tartrate - oral tablet - 10mg

Estats Units - anglès - NLM (National Library of Medicine)

allergan, inc. - progesterone (unii: 4g7ds2q64y) (progesterone - unii:4g7ds2q64y) - assisted reproductive technology crinone 8% is indicated for progesterone supplementation or replacement as part of an assisted reproductive technology ("art") treatment for infertile women with progesterone deficiency. secondary amenorrhea crinone 4% is indicated for the treatment of secondary amenorrhea. crinone 8% is indicated for use in women who have failed to respond to treatment with crinone 4%. crinone should not be used in individuals with any of the following conditions: - known sensitivity to crinone (progesterone or any of the other ingredients) - undiagnosed vaginal bleeding - liver dysfunction or disease - known or suspected malignancy of the breast or genital organs - missed abortion - active thrombophlebitis or thromboembolic disorders, or a history of hormone-associated thrombophlebitis or thromboembolic disorders crinone ® 4% and crinone ® 8% ("kri-noan") (progesterone gel) for vaginal use only you will need the following supplies: see figure a. step 1.  remove the applicator from the sealed wrapper. - open the sealed wrapper and remove the applicator. do not remove the twist-off cap at this time. see figure b. step 2. insert the plunger into the open end of the applicator. see figure c.   - hold the applicator on each side and push the plunger into the applicator until the plunger snaps into place. - you will see about 1 inch of the plunger outside of the applicator. step 3. remove the cap. see figures d and e. - remove the cap from the tip of the applicator by twisting it counterclockwise.  - do not push the plunger while you are removing the cap. this could cause some gel to come out. step 4. prepare to insert the applicator. see figure f. choose the position that is most comfortable for you. for example, lying down on your back with your knees bent. step 5. insert the applicator. see figure g. - after you are in a comfortable position, gently insert the rounded tip of the applicator into your vagina. step 6. push the plunger. see figure h. - while the applicator is inserted in your vagina, push the plunger to release the gel into your vagina. step 7. remove the applicator from your vagina and throw it away in your household trash. - it is normal for a small amount of gel to be left in the applicator. you will still get the right dose of medicine. this instructions for use has been approved by the u.s. food and drug administration. rx only for all medical inquiries contact: allergan usa, inc. irvine, ca 92612 1-800-678-1605 distributed by: allergan usa, inc. irvine, ca 92612 content updated: june 2017 © 2017 allergan. all rights reserved. crinone® is a registered trademark of allergan sales, llc. allergan® and its design are trademarks of allergan, inc. product of the netherlands. 73343us10

Singapur - anglès - HSA (Health Sciences Authority)

abbvie pte. ltd. - ophthalmology - soothing relief for dry, irritated eyes.

Singapur - anglès - HSA (Health Sciences Authority)

abbvie pte. ltd. - general & plastic surgery - intended for used for filling mid and/or deep depressions of the skin via mid and/or deep dermis injection, as well as for lip definition and enhancement. the presence of lidocaine is meant to reduce the patient’s pain during treatment.

Singapur - anglès - HSA (Health Sciences Authority)

abbvie pte. ltd. - general & plastic surgery - intended for filling any medium-sized depressions of the skin via mid-dermis injection, as well as for lip definition. the presence of lidocaine is meant to reduce the patient’s pain during treatment

Singapur - anglès - HSA (Health Sciences Authority)

abbvie pte. ltd. - general & plastic surgery - juvéderm® volbella® with lidocaine is an injectable implant used for the treatment of any fine lines and medium-sized skin depressions due to conditions such as premature aging. it can also be used for enhancement and pouting of the lips to correct structural defects such as asymmetry, contour deformities, volume loss. it is intended to be used via superficial or mid-dermis injection or lips mucosa injection by an authorized medical practitioner. for the treatment of the infraorbital skin depressions (also known as tear trough area), it is recommended to inject in the submuscular / pre- periosteal plane. the presence of lidocaine is meant to reduce the patient’s pain during treatment.

Singapur - anglès - HSA (Health Sciences Authority)

abbvie pte. ltd. - general & plastic surgery - juvéderm® volift™ with lidocaine is an injectable gel implant intended for the treatment of any deep skin depressions due to conditions such as premature aging. intended to be used for face contouring and volume restoration to correct facial structural defects such as asymmetry, contour deformities, volume loss in the lips, cheeks, chin, lower face. intended to be used via deep dermis or lips mucosa injection by an authorized medical practitioner. the presence of lidocaine is meant to reduce the patient’s pain during treatment.